Su Chen Y, Kuo Ya P, Nieh Heng-Lu, Tseng Yu H, Burnouf Thierry
Department of Dentistry, National Yang-Ming University, Taipei, Taiwan.
Transfusion. 2008 Nov;48(11):2414-20. doi: 10.1111/j.1537-2995.2008.01862.x. Epub 2008 Aug 6.
The time course of the release of growth factors from platelet (PLT) gels has not been thoroughly studied and should be elucidated for a better standardization of the clinical use of these products.
Release of PLT-derived growth factor-AB (PDGF-AB), transforming growth factor-beta1 (TGF-beta1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and insulin-like growth factor-1 (IGF-1) was determined 5, 60, 120, and 300 minutes after PLT gel formation. Control experiments where PLT gel was removed and, afterward, exogenous thrombin was added, were also performed. Protein profiles of the PLT concentrates and of the releasates were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Mean PDGF-AB, TGF-beta1, EGF, and VEGF concentration increased to 76, 114, 3.7, and 0.8 ng per mL, respectively, in the presence of the PLT gel, but remained at approximately 28, 30, 0.28, and 0.34 ng per mL, respectively, when the PLT gel was removed after formation. IGF-1 content remained unchanged (approx. 80 ng/mL). SDS-PAGE analysis showed that several PLT proteins disappear during PLT gel formation and that the protein patterns of the releasates were undistinguishable at the different time points.
There is a gradual and fast release of PDGF-AB, TGF-beta1, EGF, and VEGF from PLT gel for at least 60 to 300 minutes after gel formation, whereas the IGF releasate concentration remains unchanged. This study may provide useful information to improve clinical applications of PLT gels and to design improved blood-derived biomaterials with controlled release of growth factors.
血小板(PLT)凝胶中生长因子的释放时间过程尚未得到充分研究,为更好地规范这些产品的临床应用,应对此进行阐明。
在PLT凝胶形成后5、60、120和300分钟测定血小板衍生生长因子-AB(PDGF-AB)、转化生长因子-β1(TGF-β1)、表皮生长因子(EGF)、血管内皮生长因子(VEGF)和胰岛素样生长因子-1(IGF-1)的释放情况。还进行了对照实验,即移除PLT凝胶后再添加外源性凝血酶。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)测定PLT浓缩物和释放物的蛋白质谱。
在有PLT凝胶存在的情况下,平均PDGF-AB、TGF-β1、EGF和VEGF浓度分别增加至每毫升76、114、3.7和0.8纳克,但在凝胶形成后移除PLT凝胶时,它们分别保持在每毫升约28、30、0.28和0.34纳克。IGF-1含量保持不变(约80纳克/毫升)。SDS-PAGE分析表明,几种PLT蛋白在PLT凝胶形成过程中消失,且在不同时间点释放物的蛋白质模式无法区分。
PLT凝胶形成后至少60至300分钟内,PDGF-AB、TGF-β1、EGF和VEGF从PLT凝胶中逐渐快速释放,而IGF释放物浓度保持不变。本研究可为改善PLT凝胶的临床应用以及设计具有生长因子控释功能的改良血液衍生生物材料提供有用信息。